Furthermore, it has been reported that CD109 is highly expressed in various malignant tumors, including lung, liver, pancreas, esophagus, uterus, oral cavity, breast cancer, glioblastoma, and several types of sarcomas, and is associated with a poor prognosis [9]. This evidence concerns the gene CD109 and cancer.